These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9704758)

  • 41. Transferrin in FRTL5 cells: regulation of its receptor by mitogenic agents and its role in growth.
    Lombardi A; Tramontano D; Braverman LE; Ingbar SH
    Endocrinology; 1989 Aug; 125(2):652-8. PubMed ID: 2546742
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of Expression of the S100A8 Gene Encoding the S100 Calcium-Binding Protein A8 Promotes Apoptosis by Suppressing the Phosphorylation of Protein Kinase B (Akt) in Endometrial Carcinoma and HEC-1A Cells.
    Liu C; Xing G; Wu C; Zhu J; Wei M; Liu D; Ge Y; Chen Y; Lei T; Yang Y
    Med Sci Monit; 2018 Mar; 24():1836-1846. PubMed ID: 29595187
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of estrogen and estrogen-related growth factor in the mechanism of hormone dependency of endometrial carcinoma cells.
    Hata H; Hamano M; Watanabe J; Kuramoto H
    Oncology; 1998 Dec; 55 Suppl 1():35-44. PubMed ID: 9852400
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of normal endometrial stroma on growth and differentiation in Ishikawa endometrial adenocarcinoma cells.
    Arnold JT; Lessey BA; Seppälä M; Kaufman DG
    Cancer Res; 2002 Jan; 62(1):79-88. PubMed ID: 11782363
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of gastrin-releasing peptide receptors in endometrial cancer.
    Levine L; Licci JA; Townsend CM; Hellmich MR
    J Am Coll Surg; 2003 Jun; 196(6):898-904. PubMed ID: 12788426
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Direct interaction between human endometrial carcinoma and fibroblast: fibroblast-derived growth factor.
    Tamaya T; Sato S; Imai A
    Res Commun Chem Pathol Pharmacol; 1991 Sep; 73(3):367-70. PubMed ID: 1947445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A newly characterized human endometrial adenocarcinoma cell line (CAC-1) differentiates in response to retinoic acid treatment.
    Carter CA; Madden VJ
    Exp Mol Pathol; 2000 Dec; 69(3):175-91. PubMed ID: 11115359
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transforming growth factor beta: potential autocrine growth inhibitor of estrogen receptor-negative human breast cancer cells.
    Arteaga CL; Tandon AK; Von Hoff DD; Osborne CK
    Cancer Res; 1988 Jul; 48(14):3898-904. PubMed ID: 3164252
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions of cathepsin-D and insulin-like growth factor-II (IGF-II) on the IGF-II/mannose-6-phosphate receptor in human breast cancer cells and possible consequences on mitogenic activity of IGF-II.
    Mathieu M; Rochefort H; Barenton B; Prebois C; Vignon F
    Mol Endocrinol; 1990 Sep; 4(9):1327-35. PubMed ID: 2172799
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Activin A inhibits growth-inhibitory signals by TGF-beta1 in differentiated human endometrial adenocarcinoma cells.
    Tanaka T; Toujima S; Umesaki N
    Oncol Rep; 2004 Apr; 11(4):875-9. PubMed ID: 15010888
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Regulation of human progesterone receptor isoforms A and B in uterine endometrial carcinoma by estrogen and insulin-like growth factor-1].
    Zhang X; Wei L; Wang J; Tu Z
    Zhonghua Yi Xue Za Zhi; 2002 Jun; 82(12):836-9. PubMed ID: 12126534
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Receptor binding and growth-promoting activity of insulin-like growth factors in human breast cancer cells (T-47D) in culture.
    Myal Y; Shiu RP; Bhaumick B; Bala M
    Cancer Res; 1984 Dec; 44(12 Pt 1):5486-90. PubMed ID: 6093996
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of retinoic acid on cell differentiation and reversion toward normal in human endometrial adenocarcinoma (RL95-2) cells.
    Carter CA; Pogribny M; Davidson A; Jackson CD; McGarrity LJ; Morris SM
    Anticancer Res; 1996; 16(1):17-24. PubMed ID: 8615604
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prospective clinical study of the association between plasma level of free IGF-1 and myometrial invasion min patients with endometrial adenocarcinoma.
    Baloglu A; Bezircioglu I; Cetinkaya B; Hicyilmaz L
    Ginekol Pol; 2010 Jul; 81(7):501-5. PubMed ID: 20825050
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidermal growth factor activates protein kinase C in the human endometrial cancer cell line HEC-1-A.
    Connor P; Talavera F; Kang JS; Burke J; Roberts J; Menon KM
    Gynecol Oncol; 1997 Oct; 67(1):46-50. PubMed ID: 9345355
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hepatocyte growth factor (HGF) induces invasion of endometrial carcinoma cell lines in vitro.
    Bae-Jump V; Segreti EM; Vandermolen D; Kauma S
    Gynecol Oncol; 1999 May; 73(2):265-72. PubMed ID: 10329045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The expression and role of hybrid insulin/insulin-like growth factor receptor type 1 in endometrial carcinoma cells.
    Zhang G; Li X; Zhang L; Zhao L; Jiang J; Wang J; Wei L
    Cancer Genet Cytogenet; 2010 Jul; 200(2):140-8. PubMed ID: 20620597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: evidence for autocrine/paracrine regulation of growth factor action.
    Rutanen EM; Pekonen F; Mäkinen T
    J Clin Endocrinol Metab; 1988 Jan; 66(1):173-80. PubMed ID: 2961785
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins.
    Kleinman D; Karas M; Danilenko M; Arbell A; Roberts CT; LeRoith D; Levy J; Sharoni Y
    Endocrinology; 1996 Mar; 137(3):1089-95. PubMed ID: 8603578
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Secretion and biological actions of insulin-like growth factor binding proteins in two human tumor-derived cell lines in vitro.
    Camacho-Hubner C; McCusker RH; Clemmons DR
    J Cell Physiol; 1991 Aug; 148(2):281-9. PubMed ID: 1715344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.